Reports for TEVA-CANDESARTAN/HCTZ
Brand name
TEVA-CANDESARTAN/HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02395541 |
Ingredients
CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE |
Ingredient Strength
16 MG 12.5 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-CANDESARTAN/HCTZ | 30 | Resolved | 2019-06-18 | 2020-04-23 | 86963 |
| TEVA-CANDESARTAN/HCTZ | P/P 30 | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
| TEVA-CANDESARTAN/HCTZ | PP | Actual shortage | 2024-09-19 | 2025-08-08 | 237989 |
Showing 1 to 3 of 3
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0